Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021:1339:301-308.
doi: 10.1007/978-3-030-78787-5_35.

The Effect of Nutrients on Alzheimer's Disease Biomarkers: A Metabolomic Approach

Εfstathia G Kalli  1
Affiliations

The Effect of Nutrients on Alzheimer's Disease Biomarkers: A Metabolomic Approach

Εfstathia G Kalli. Adv Exp Med Biol. 2021.

Abstract

A large number of plasma proteomic biomarkers have been discovered in the field of neurodegenerative diseases. Novel biomarker molecules in plasma and serum could significantly reduce the need for invasive methods in clinical practice such as the lumbar puncture for CSF collection and may be useful to specific patients. Furthermore, candidate biomarker proteins that have been identified and validated could be used to discriminate Αlzheimer's disease patients from MCI and healthy controls in clinical trials, before the onset of clinical symptoms as well as to improve personalized therapies. The development of new blood-based biomarkers via proteomic technology offers a deep knowledge in the pathophysiology of neurodegenerative diseases and involves in the development of new therapeutic _targets. This report presents numerous dietary compounds that either promote or suppress the expression of biomarkers mainly in the blood of AD or MCI subjects.

Keywords: Nutrients; Plasma proteomic biomarkers; Αlzheimer’s.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Aitken JF, Loomes KM, Riba-Garcia I, Unwin RD, Prijic G, Phillips AS et al (2017) Rutin suppresses human-amylin/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin/hIAPP transgenic mice. Biochem Biophys Res Commun 482(4):625–631 - PubMed
    1. Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji OR et al (2016) Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: a randomized, double-blind and controlled trial. Front Aging Neurosci 8:256 - PubMed - PMC
    1. Angeloni C, Hrelia S, Malaguti M (2016) Neuroprotective effects of glucosinolates. In: Glucosinolates. Springer International Publishing, Cham, pp 1–25
    1. Ashton NJ, Nevado-Holgado AJ, Barber IS, Lynham S, Gupta V, Chatterjee P et al (2019) A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease. Sci Adv 5(2):eaau7220 - PubMed - PMC
    1. Bahn G, Jo DG (2019) Therapeutic approaches to Alzheimer’s disease through modulation of NRF2. NeuroMolecular Med 21(1):1–11 - PubMed

LinkOut - more resources

  NODES
chat 1
INTERN 1
twitter 2